Overview

Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation

Status:
Unknown status

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The investigators believe that the local anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) cream will lessen pain and reduce the need for anesthesia and analgesia, when implanting a permanent pacemaker.

Phase:

N/A

Details

Lead Sponsor:

Hillel Yaffe Medical Center

Treatments:

Analgesics
EMLA
Meperidine
Midazolam